Home
Windlas Biotech

Windlas Biotech Market Share Analysis for July 2026

Learn the Monitoring Agency overseeing Windlas Biotech’s IPO fund usage, ensuring transparency, accountability, & proper fund deployment.

Finance > Investing

Domainwindlas.com

Year Founded2001

Employees201 - 500

Annual Revenue$75M - $100M

Windlas Biotech

Windlas Biotech (including company regionals)

windlas.com

See more website traffic and engagement information

Windlas Biotech Revenue up to July 2026 is 75M - 100M

revenue generated by Windlas Biotech top domains

Windlas Biotech top domains revenue over 3 years

Revenue for Windlas Biotech top domains

windlas.com75M - 100M

See more with Sales Intelligence

Total visits to Windlas Biotech's top domains

Understand Windlas Biotech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

windlas.com5.2K

See more with Sales Intelligence

Avg. visit duration in Windlas Biotech's top domains

Analyze Windlas Biotech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

windlas.com00:00:13

See more with Sales Intelligence

Avg. pageviews on Windlas Biotech's top domains

See how Windlas Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

windlas.com1.80

See more with Sales Intelligence

Windlas Biotech top competitors by domain

Top similar sites in July 2026, ranked by their affinity

bdrpharma.comCompany NameBDR Pharmaceuticals InternationalsEmployees51 - 200HQIndia, MumbaiAnnual revenue$100M - $200MTotal visits3.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Windlas Biotech

These are the website technologies, by industry, used by Windlas Biotech top domains

Widget (5)

Twemoji

Payment & Currencies (4)

Cart Functionality

Advertising (3)

Google Adsense

Audio Video Media (3)

YouTube

More Technologies

10

See all

News & Signals from Windlas Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsWindlas Biotech Limited had revenue of $26M on Jun 30th '26.Windlas Biotech Limited (NSE:WINDLAS) informed stock exchanges on 10 August 2026 that its Board of Directors approved unaudited standalone financial results for the quarter ended 30 June 2026, with revenue from operations reaching Rs 2,480.99 million and profit after tax of Rs 176.53 million.

NewsWindlas Biotech Limited hires Shailendra Rastogi as Chief Business Officer.Windlas Biotech Limited, one of the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry in India has further strengthened the senior management capability with the appointment of Shailendra Rastogi as a Chief Business Officer.

NewsWindlas Biotech Limited went public on Aug 4th '21.(Image: Windlas Biotech) Windlas Biotech IPO share allotment status: The initial public offering (IPO) of Windlas Biotech, a manufacturer of pharmaceutical formulations, was subscribed 22.47 times over the 61.36 lakh shares that were on offer during the subscription period from August 4-6, 2021.